This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Indiana University, University of Toronto, Uti Limited Partnership. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 809 
2 out of 530 
2 out of 139 
Years Active: 2017-2019
Title: Hema Artee Luchman: Innovator in Pharmaceutical Chemistry
Introduction
Hema Artee Luchman is a notable inventor based in Calgary, Canada. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for cancer treatment. With two patents to her name, her work focuses on innovative solutions for complex medical challenges.
Latest Patents
Luchman's latest patents include advancements in salicylic acid derivatives. These patents detail pharmaceutically acceptable salts, compositions, and methods for inhibiting STAT3 and/or STAT5 activity. The inventions aim to provide effective treatments for STAT3 or STAT5-dependent cancers, showcasing her commitment to addressing critical health issues through scientific innovation.
Career Highlights
Throughout her career, Luchman has worked with esteemed institutions, including the University of Toronto and Uti Limited Partnership. Her experience in these organizations has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Luchman has collaborated with notable colleagues such as Patrick Thomas Gunning and Sina Haftchenary. These partnerships have enriched her research and expanded the impact of her inventions in the pharmaceutical industry.
Conclusion
Hema Artee Luchman exemplifies the spirit of innovation in pharmaceutical chemistry. Her patents and collaborations reflect her dedication to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile